PuraPharm Corp. Ltd.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: KYG7306Y1044

HKD

0.30

-0.2 (-39.0%)

Apr 02

HKG

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.

Zhongzhi Pharmaceutical Holdings Ltd.

China Shineway Pharmaceutical Group Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

HBM Holdings Ltd.

Sihuan Pharmaceutical Holdings Group Ltd.

CK Life Sciences International (Holdings), Inc.

Wai Yuen Tong Medicine Holdings Ltd.

Hin Sang Group (International) Holding Co. Ltd.

China Health Group, Inc.

PuraPharm Corp. Ltd.

Why is PuraPharm Corp. Ltd. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is PuraPharm Corp. Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

PuraPharm Corp. Ltd.

-100.0%

-1.69

35.49%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-11.61%

EBIT Growth (5y)

4.40%

EBIT to Interest (avg)

-0.97

Debt to EBITDA (avg)

7.83

Net Debt to Equity (avg)

2.83

Sales to Capital Employed (avg)

0.70

Tax Ratio

21.83%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.42%

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.75

EV to EBIT

-15.61

EV to EBITDA

23.19

EV to Capital Employed

1.18

EV to Sales

1.43

PEG Ratio

Dividend Yield

ROCE (Latest)

-7.57%

ROE (Latest)

-36.59%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

Higher at HKD -21.54 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 1.39 times

DEBTORS TURNOVER RATIO(HY)

Highest at 6.49 times

-3What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 328.52 %

NET SALES(Q)

Lowest at HKD 172.29 MM

Here's what is working for PuraPharm Corp. Ltd.

Net Profit

Higher at HKD -21.54 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Inventory Turnover Ratio

Highest at 1.39 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 6.49 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for PuraPharm Corp. Ltd.

Debt-Equity Ratio

Highest at 328.52 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Net Sales

Lowest at HKD 172.29 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (HKD MM)